相似文献
1
Preventing cervical cancer globally by acting locally: if not now, when?
J Natl Cancer Inst. 2010 Oct 20;102(20):1524-7. doi: 10.1093/jnci/djq382. Epub 2010 Sep 30.
2
A new generation of studies of human papillomavirus DNA testing in cervical cancer screening.
J Natl Cancer Inst. 2009 Dec 2;101(23):1600-1. doi: 10.1093/jnci/djp392. Epub 2009 Nov 9.
3
Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.
J Natl Cancer Inst. 2010 Oct 20;102(20):1557-67. doi: 10.1093/jnci/djq342. Epub 2010 Sep 30.
4
Re: Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
J Natl Cancer Inst. 2010 May 19;102(10):739; author reply 739-40. doi: 10.1093/jnci/djq109. Epub 2010 Apr 1.
5
Re: Preventing cervical cancer globally by acting locally: if not now, when?
J Natl Cancer Inst. 2011 Apr 6;103(7):611-2; author reply 612-3. doi: 10.1093/jnci/djr049. Epub 2011 Mar 30.
6
Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
J Natl Cancer Inst. 2009 Dec 2;101(23):1612-23. doi: 10.1093/jnci/djp367. Epub 2009 Nov 9.
7
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.
J Natl Cancer Inst. 2008 Apr 2;100(7):492-501. doi: 10.1093/jnci/djn065. Epub 2008 Mar 25.
8
Is it time to introduce HPV self-sampling for primary cervical cancer screening?
J Natl Cancer Inst. 2012 Feb 8;104(3):166-7. doi: 10.1093/jnci/djr544. Epub 2012 Jan 23.
9
Have we resolved how to triage equivocal cervical cytology?
J Natl Cancer Inst. 2004 Feb 18;96(4):250-1. doi: 10.1093/jnci/djh063.
10
Expanded use of human papillomavirus testing in gynecologic practice.
Am J Clin Pathol. 2007 Nov;128(5):886-8; author reply 888-90.
引用本文的文献
1
Effects of religion, politics and distance to providers on HPV vaccine attitudes and intentions of parents in rural Utah.
PLoS One. 2024 Oct 23;19(10):e0312549. doi: 10.1371/journal.pone.0312549. eCollection 2024.
2
A low-cost, paper-based hybrid capture assay to detect high-risk HPV DNA for cervical cancer screening in low-resource settings.
Lab Chip. 2023 Jan 31;23(3):451-465. doi: 10.1039/d2lc00885h.
3
Triage of Women Testing Positive With the careHPV Test on Self-Collected Vaginal Samples for Cervical Cancer Screening in a Low-Resource Setting.
J Glob Oncol. 2018 Sep;4:1-7. doi: 10.1200/JGO.2016.008078. Epub 2017 Sep 29.
4
Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential.
Cancer Prev Res (Phila). 2012 Jan;5(1):11-7. doi: 10.1158/1940-6207.CAPR-11-0540. Epub 2011 Dec 12.
5
A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test.
J Virol Methods. 2011 Sep;176(1-2):112-4. doi: 10.1016/j.jviromet.2011.05.024. Epub 2011 May 27.
6
Lessons learned from successful Papanicolaou cytology cervical cancer prevention in the Socialist Republic of Vietnam.
Diagn Cytopathol. 2012 Apr;40(4):355-66. doi: 10.1002/dc.21655. Epub 2011 Mar 10.
本文引用的文献
1
Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.
J Natl Cancer Inst. 2010 Oct 20;102(20):1557-67. doi: 10.1093/jnci/djq342. Epub 2010 Sep 30.
2
Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women.
AIDS. 2010 Oct 23;24(16):2553-61. doi: 10.1097/QAD.0b013e32833e163e.
3
Using biomarkers as objective standards in the diagnosis of cervical biopsies.
Am J Surg Pathol. 2010 Aug;34(8):1077-87. doi: 10.1097/PAS.0b013e3181e8b2c4.
4
HIV acquisition is associated with prior high-risk human papillomavirus infection among high-risk women in Rwanda.
AIDS. 2010 Sep 10;24(14):2289-92. doi: 10.1097/QAD.0b013e32833cbb71.
5
Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme.
BMJ. 2010 Apr 27;340:c1804. doi: 10.1136/bmj.c1804.
6
Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection.
J Infect Dis. 2010 Jun 1;201(11):1677-85. doi: 10.1086/652408.
7
The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe.
AIDS. 2010 Apr 24;24(7):1035-42. doi: 10.1097/qad.0b013e3283377973.
8
Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections.
PLoS One. 2010 Apr 8;5(4):e10094. doi: 10.1371/journal.pone.0010094.
9
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.
Lancet Oncol. 2010 Mar;11(3):249-57. doi: 10.1016/S1470-2045(09)70360-2. Epub 2010 Jan 18.
10
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.
Lancet. 2009 Jul 25;374(9686):301-14. doi: 10.1016/S0140-6736(09)61248-4. Epub 2009 Jul 6.
Zotero 插件